NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 4.85% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 4.66% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 4.64% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.42% |
| DNTH | Dianthus Therapeutics Inc. | Healthcare | Biotechnology | 4.41% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 4.35% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 4.31% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.93% |
| CNTA | Centessa Pharmaceuticals PLC ADR | Healthcare | Biotechnology | 3.86% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 3.81% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 3.71% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.71% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.66% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.58% |
| EWTX | Edgewise Therapeutics Inc | Healthcare | Biotechnology | 3.46% |